Tim Fite continues to rule – now so more than ever because he’s decided to give away his awesome second album ‘Over the Counter Culture’ FOR 100% FREE… Fite will release his new album Over The Counter ...

Brooklyn, NY-based indie/country/hip-hop musician Tim Fite has announced some details about his upcoming record that might not have his record label, Anti-, too excited, but them's the breaks. In May, ...

FITE has a new name. The successful streaming app has rebranded as TrillerTV to better align with its parent company, Triller. The FITE PPV platform, subscription channel (formerly FITE+), and FAST ...

Tim Fite‘s debut, “Gone Ain’t Gone,” is apparently largely an assembled patchwork of samples, or, as his label would have it, “a wry, anachronistic, copyright-defying, country/hip-hop collage” that ...

PETACH TIKVA, Israel, March 30, 2015 -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (CFBI.TA), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and ...

PETACH TIKVA, Israel, April 27, 2015 -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and ...

Ramat Gan, Israel, March 20, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs ...

RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for ...

PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that bind specifically to ...

PETACH TIKVA, Israel,--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address ...